We’re here to help you achieve your strategic objectives.
A Second Wave of Autism Services Investing
September 30, 2025 | Insights
Few healthcare sectors represent as compelling an opportunity for investors to increase access to care in response to skyrocketing demand as autism services and applied behavioral analysis (ABA). Improved company financial health and a steady rhythm of successful trades at a variety of check sizes has paved the way for accelerated activity in late 2025 and 2026. Despite some reimbursement headwinds, investors are continuing to pursue clinically rigorous, high-quality assets that are well positioned to expand their reach. This “second wave” of ABA investment is characterized by more disciplined growth, tighter operating models, and exploration of emerging care methods and delivery modalities that can improve efficiency, access to care, and clinical quality.
Download the report by filling out the form. Please contact us to request more information.
Note: As ABA’s “second wave” continues to emerge, we are re-publishing this research note, originally released in April 2025, with updated market commentary and reimbursement details.
Download Now
CONTACT INFORMATION
Russell Bryan
Managing Director
Phillip Knotts
Managing Director
Ben Matz
Managing Director
Rebecca Springer
Senior Director, Market Development
ABOUT BAILEY & COMPANY
Bailey & Company is a Nashville-based merchant banking platform focused on middle market healthcare companies in the healthcare services, healthcare technology, payer services and pharma services/medtech/life sciences sectors. As one of the largest independent, sector-focused investment banking and investing platforms in the country, Bailey & Company supports strong management teams that have built scalable platforms by providing strategic insights, world-class advice and access to one of the most diverse networks of industry experts. For more information see: www.bnco.com
